PMID: 8592132Feb 1, 1996Paper

Synthetic analogues of conantokin-G: NMDA antagonists acting through a novel polyamine-coupled site

Journal of Neurochemistry
L M ZhouL Otvos

Abstract

Conantokin-G (con-G) is a 17-amino-acid polypeptide that acts as an N-methyl-D-aspartate (NMDA) antagonist. This action has been attributed to a specific but noncompetitive inhibition of the positive modulatory effects of polyamines at NMDA receptors. Con-G possesses several unusual structural features, including five gamma-carboxyglutamate (Gla) residues and a high degree of helicity in aqueous media. Previous structure-activity studies indicated that one or more Gla residues are necessary for NMDA antagonist activity. Con-G analogues were synthesized with alanine (Ala), serine (Ser), and phosphoserine substituted for Gla to assess the contribution of individual Gla residues to biological activity and secondary structure. Replacement of Gla in positions 3 and 4 resulted in polypeptides with markedly reduced and no NMDA antagonist actions, respectively. In contrast, Gla residues in positions 7, 10, and 14 are not required for NMDA antagonist actions because the potencies of con-G analogues containing Ser7, Ser10, Ala14, and Ser14 to inhibit spermine-stimulated [3H]MK-801 binding are similar to the parent peptide. Moreover, the Ala7 derivative of con-G was about fourfold more potent than the parent peptide both as an inhibitor o...Continue Reading

Citations

May 20, 1998·Natural Product Reports·M G Moloney
Jul 16, 1999·The Journal of Peptide Research : Official Journal of the American Peptide Society·T BlandlF J Castellino
Aug 6, 1999·Protein Engineering·C H LinP C Lyu
May 2, 2001·Journal of Neurochemistry·S E WarderM Prorok
Dec 13, 2005·Journal of Neurochemistry·L RagnarssonD J Adams
Jan 24, 1997·The Journal of Biological Chemistry·N SkjaerbaekD J Craik
May 20, 2003·The Journal of Peptide Research : Official Journal of the American Peptide Society·R C KleinF J Castellino
Oct 8, 1998·FEBS Letters·T BlandlF J Castellino
Apr 1, 2007·Expert Opinion on Drug Discovery·Marianne A GrantAlan C Rigby
Dec 11, 2002·European Journal of Biochemistry·Antonia A ClaaszJohn D Wade
Nov 30, 2000·The Journal of Biological Chemistry·T BlandlF J Castellino
May 25, 2015·Asian Pacific Journal of Tropical Medicine·Palanisamy Satheesh KumarSundaresan Umamaheswari
Aug 23, 2000·Molecular Pharmacology·S D Donevan, R T McCabe
Jul 8, 1998·European Journal of Pharmacology·J A Segal, P Skolnick
May 18, 2004·Brain Research. Brain Research Reviews·Wudayagiri RajendraKandiah Jeyaseelan
Jun 15, 2004·Biochemical and Biophysical Research Communications·Karin HanssonJohan Stenflo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.